News | Information Technology | July 14, 2020

Epic's Risk-Scoring Algorithms Help Health Systems Get Back on Course

Reopening for elective and routine care is critical to keep people healthy and help healthcare organizations recover financially

July 14, 2020 — The COVID-19 pandemic caused healthcare organizations to cancel most routine and elective services. The results were devastating. By early April, screenings for breast, colon, and cervical cancer were at historic lows, people with symptoms of heart attack and stroke avoided emergency rooms, and healthcare organizations' budgets were in tatters. Groups using Epic reported an 86-94% reduction in cancer screenings, 45% fewer emergency room visits for heart attack and 38% fewer for stroke, and nearly $170 billion in losses due to reduced and cancelled services.

Reduced schedules, essential for social distancing, have put available appointments at a premium and generated a large backlog of patients waiting to be seen. To help organizations determine which appointments to reschedule first, Epic provides risk-scoring algorithms that look at factors such as age, chronic conditions, obesity, and previous hospitalizations. This information helps them prioritize appointments.

"Using Epic's risk-scoring algorithms to re-start services, we can make sure we're getting the patients who need care most urgently in to see their doctor first," said Deborah Gash of Saint Luke's Health System in Kansas City, Missouri. "As we prepared for COVID-19, routine visits and elective surgeries virtually disappeared, and many of our waiting rooms and doctors' offices remained empty. In addition to the impact this had on our patients' health, this had a financial impact on the organization – which has required us to rethink how we provide care, embrace technology to streamline operations, eliminate certain services, and close some operations. We are on the road to recovery but are committed to continually leveraging Epic and its capabilities to strengthen our organization."

Hundreds of other healthcare organizations have used risk scoring to restart services. Starting in late March, groups using Epic decreased their routine and elective care by as much as 55%. Today, most are back to within 10%-20% of their pre-pandemic visit volumes.

"We're helping hospitals and clinics understand how to prioritize appointments as they reopen, allowing patients to get the care they need while restoring the financial health of our customers," said Chris Mast, M.D., Epic's Vice President of Clinical Informatics. 

For more information: www.epic.com/about

Related Content

Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to augment medical research and enable scientific discoveries, presented findings in Hepatocellular Carcinoma (HCC) with Cleveland Clinic at the 2021 European Society of Medical Oncology (ESMO) conference.

Illustration courtesy of Cleveland Clinic

News | Artificial Intelligence | September 24, 2021
September 24, 2021 — Owkin, a startup that deploys...
Doctors say they should be making medical decisions with patients, not insurance carriers and outline principles for noninvasive testing
News | Cardiac Imaging | September 23, 2021
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by
GE has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

Getty Images

News | Radiology Business | September 23, 2021
September 23, 2021 — GE has entered into an
Paige Prostate, is the first artificial intelligence (AI)-based software designed to identify an area of interest on the prostate biopsy image with the highest likelihood of harboring cancer so it can be reviewed further by the pathologist if the area of concern has not been identified on initial review.
News | Digital Pathology | September 22, 2021
September 22, 2021 — The U.S.
This study shows that thanks to deep learning analysis applied to digitized pathology slides, artificial intelligence can classify patients with localized breast cancer between high risk and low risk of metastatic relapse in the next five years.

Getty Images

News | Artificial Intelligence | September 22, 2021
September 22, 2021 — The RACE AI study conducted by Gustave...
HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed research recently published in the journal Cancers has demonstrated the ability of its radiomics technology to identify biomarkers that predict whether patients with lung adenocarcinoma would benefit from immunotherapy.

Semi-automatic lesion identification: (A) Manual ROI indication. In blue, it is possible to observe the axes that cross the lesion manually delineated by the radiologist on a plane of the MPR. The intensity of the lesion boundary (estimated) is represented with a red outline. (B) Additional axes can be dragged onto other orthogonal MPR views. From left to right, it is possible to observe the initial long axis outlined by the radiologist and the 2D contours on the axial, coronal and sagittal views of the lesion used as a starting point for the RPM algorithms. (C) Resulting 3D contour of the lesion (in blue).

News | Radiomics | September 21, 2021
September 21, 2021 —  HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed ...
News | Breast Imaging | September 20, 2021
September 20, 2021 — ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of...
Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., a healthcare performance improvement company, effective Sept. 1, 2021.
News | X-Ray | September 17, 2021
September 17, 2021 — Shimadzu Medical Systems USA, a leading manufacturer of advanced medical...
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI

Getty Images

News | Contrast Media Injectors | September 16, 2021
September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthc